-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
Kenvue (KVUE) delivered solid Q1 results with net sales of $3,909M (+4.5% Y/Y) and organic growth of 0.7%, marking the second consecutive quarter of growth. Diluted EPS surged to $0.25 vs. $0.17 (+47%) while adjusted EPS reached $0.32 vs $0.24 (+33%), due to significant margin expansion with gross margin improving 90bps to 58.9% and operating margin jumping 470bps to 19.6%. The strong performance demonstrates operational momentum ahead of the pending Kimberly-Clark acquisition, with supply chain optimization and cost management initiatives driving results. . Segment performance was mixed, with Skin Health & Beauty leading at +8.4% growth while Self Care faced headwinds from weak cold/flu seasons, posting an organic sales decline of 2.3%. Since management is no longer providing forward guidance and hosting an analyst call due to the transaction expected to close during 2H 2026, we have limited visibility into KVUE's performance expectations at this point.